185 related articles for article (PubMed ID: 35170195)
1. Long noncoding RNA CCAT2 reduces chemosensitivity to 5-fluorouracil in breast cancer cells by activating the mTOR axis.
Zhou D; Gu J; Wang Y; Luo B; Feng M; Wang X
J Cell Mol Med; 2022 Mar; 26(5):1392-1401. PubMed ID: 35170195
[TBL] [Abstract][Full Text] [Related]
2. Effect of long noncoding RNA CCAT2 on drug sensitivity to 5-fluorouracil of breast cancer cells through microRNA-145 meditated by p53.
Zhang Z; Wang X; Wang Y; Zhou D; Wu H; Cheng W; Wang Q; Zheng G; Wang J; Gu J
J Biochem Mol Toxicol; 2022 Nov; 36(11):e23176. PubMed ID: 35968984
[TBL] [Abstract][Full Text] [Related]
3. CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p/AKT3/mTOR axis in tamoxifen-resistant MCF7 cells.
Moradi F; Mohajerani F; Sadeghizadeh M
Life Sci; 2022 Dec; 311(Pt B):121183. PubMed ID: 36375570
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
Lu PW; Li L; Wang F; Gu YT
J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
Yu S; Wu C; Tan Q; Liu H
J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of circular RNA CDR1as increases chemosensitivity of 5-FU-resistant BC cells through up-regulating miR-7.
Yang W; Gu J; Wang X; Wang Y; Feng M; Zhou D; Guo J; Zhou M
J Cell Mol Med; 2019 May; 23(5):3166-3177. PubMed ID: 30884120
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.
Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
9. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.
Chen B; Dragomir MP; Fabris L; Bayraktar R; Knutsen E; Liu X; Tang C; Li Y; Shimura T; Ivkovic TC; De Los Santos MC; Anfossi S; Shimizu M; Shah MY; Ling H; Shen P; Multani AS; Pardini B; Burks JK; Katayama H; Reineke LC; Huo L; Syed M; Song S; Ferracin M; Oki E; Fromm B; Ivan C; Bhuvaneshwar K; Gusev Y; Mimori K; Menter D; Sen S; Matsuyama T; Uetake H; Vasilescu C; Kopetz S; Parker-Thornburg J; Taguchi A; Hanash SM; Girnita L; Slaby O; Goel A; Varani G; Gagea M; Li C; Ajani JA; Calin GA
Gastroenterology; 2020 Dec; 159(6):2146-2162.e33. PubMed ID: 32805281
[TBL] [Abstract][Full Text] [Related]
10. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations.
Redis RS; Sieuwerts AM; Look MP; Tudoran O; Ivan C; Spizzo R; Zhang X; de Weerd V; Shimizu M; Ling H; Buiga R; Pop V; Irimie A; Fodde R; Bedrosian I; Martens JW; Foekens JA; Berindan-Neagoe I; Calin GA
Oncotarget; 2013 Oct; 4(10):1748-62. PubMed ID: 24077681
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.
Xin S; Ye X
Int J Mol Med; 2020 Dec; 46(6):2047-2056. PubMed ID: 33125134
[TBL] [Abstract][Full Text] [Related]
12. TMEM97 knockdown inhibits 5-fluorouracil resistance by regulating epithelial-mesenchymal transition and ABC transporter expression via inactivating the Akt/mTOR pathway in 5-fluorouracil-resistant colorectal cancer cells.
Xu Y; Tang Y; Xu Q; He W
Chem Biol Drug Des; 2024 Feb; 103(2):e14490. PubMed ID: 38388887
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.
Wu C; Luo J
Med Sci Monit; 2016 Oct; 22():3860-3867. PubMed ID: 27765938
[TBL] [Abstract][Full Text] [Related]
14. RBM8A Depletion Decreases the Cisplatin Resistance and Represses the Proliferation and Metastasis of Breast Cancer Cells via AKT/mTOR Pathway.
Song T; Zhang H
Breast J; 2022; 2022():4576789. PubMed ID: 36105365
[TBL] [Abstract][Full Text] [Related]
15. ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells.
Wang X; Wang Y; Gu J; Zhou D; He Z; Wang X; Ferrone S
Sci Rep; 2017 Aug; 7(1):9687. PubMed ID: 28852196
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells.
Yang C; Pan Y; Deng SP
BMC Mol Cell Biol; 2019 Apr; 20(1):9. PubMed ID: 31039730
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNORD3A specifically sensitizes breast cancer cells to 5-FU by sponging miR-185-5p to enhance UMPS expression.
Luo L; Zhang J; Tang H; Zhai D; Huang D; Ling L; Wang X; Liu T; Zhang Q; Zhang Z; He Z; Zheng G
Cell Death Dis; 2020 May; 11(5):329. PubMed ID: 32382150
[TBL] [Abstract][Full Text] [Related]
18. LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway.
Tang C; Li C; Chen C; Chen T; Zhu J; Sun M; Wang P; Han C
Taiwan J Obstet Gynecol; 2024 Jan; 63(1):46-56. PubMed ID: 38216268
[TBL] [Abstract][Full Text] [Related]
19. Extract of
Cui XL; Li KJ; Ren HX; Zhang YJ; Liu XD; Bu BG; Wang L
World J Gastroenterol; 2019 Apr; 25(15):1854-1864. PubMed ID: 31057299
[TBL] [Abstract][Full Text] [Related]
20. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
